---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-21-056757"
form_type: "8-K"
ticker: "SRTS"
cik: "0001494891"
company_name: "Sensus Healthcare, Inc."
filed_at: "2021-11-04T23:59:59+00:00"
generated_at: "2026-06-28T12:51:42.499895+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Sensus Healthcare Q3 revenue $5.5M (+244% YoY); reports first profitable Q3, net income $0.2M

## Summary
- Revenue $5.5M, up 244% from $1.6M in Q3 2020; net income $0.2M vs loss of $1.7M.
- Adjusted EBITDA positive $0.5M vs negative $1.5M; shipped 14 systems including 8 SRT-100 Vision.
- Affirms Q4 and full-year 2021 profitability; five-year license renewal from Chinese Health Authority through Dec 2026.
- Diluted EPS $0.01 vs ($0.10); gross margin expanded to 57.9% from 41.5%.

## SEC filing metadata
- accession: 0001213900-21-056757
- form_type: 8-K
- ticker: SRTS
- cik: 0001494891
- company_name: Sensus Healthcare, Inc.
- filed_at: 2021-11-04T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1494891/000121390021056757/0001213900-21-056757-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1494891/000121390021056757/ea149717-8k_sensushealth.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-21-056757
- JSON: https://secwatch.observer/filing/0001213900-21-056757.json
- Plain text: https://secwatch.observer/filing/0001213900-21-056757.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.